Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Koege – page 4

65 clinical trials in Koege, Denmark across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Koege at a glance
65
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

65 trials in Koege

Open in trial search

Peritonitis

Not yet recruiting

Study on Intraperitoneal Treatment with Fosfomycin, Metronidazole, and Molgramostim for Patients with Multi-Quadrant Peritonitis Undergoing Abdominal Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Fosfomycin
  • Sponsor:Region Sjaelland

Colorectal cancer

Not yet recruiting

Study on Electrochemotherapy with Bleomycin for Patients with Colorectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bleomycin
  • Sponsor:Region Sjaelland

Study on the Effectiveness and Safety of Brensocatib for Patients with Chronic Rhinosinusitis Without Nasal Polyps

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Brensocatib
  • Sponsor:Insmed Inc.

Sjogren's syndrome

Not recruiting

Study on the Effectiveness and Safety of Nipocalimab for Adults with Moderate to Severe Sjögren's Disease

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nipocalimab
  • Sponsor:Janssen Cilag International

Study of Obexelimab Treatment for Adults with Systemic Lupus Erythematosus (SLE)

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Obexelimab
  • Sponsor:Zenas Biopharma (USA) LLC

Psoriatic arthropathy

Not recruiting

Study on Guselkumab for Treating Psoriatic Arthritis in Patients New to Biologic Therapy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International

Study on the Safety and Effectiveness of ESK-001 for Adults with Systemic Lupus Erythematosus

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:ESK-001
  • Sponsor:Alumis Inc.

Type 1 diabetes mellitus+2

Not recruiting

Efficacy and Safety of Tirzepatide Versus Placebo in Adults with Type 1 Diabetes and Obesity or Overweight: A Phase 3 Randomized Controlled Trial

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Tirzepatide
  • Sponsor:Eli Lilly & Co.

Long‑term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasal polyps: an extension study

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Obesity

Not recruiting

A study to evaluate the efficacy and safety of zenagamtide in people with obesity

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Obesity

Not recruiting

Study on How Cagrilintide and Semaglutide Help People with Overweight or Obesity Reduce Weight

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Novo Nordisk A/S

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Itepekimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Denmark

The busiest research cities in the country

All 48 cities in Denmark

Clinical research in Koege

What the registry says about research in the country

01 Cardiovascular and Emergency Care Research

Clinical trials in Køge are exploring cardiovascular diseases and acute care, with a focus on improving outcomes for patients with hypotension and shock. These studies are designed to test new treatment approaches that may help stabilize patients faster and reduce the need for intensive care.

  • Early treatment strategies for low blood pressure and shock
  • New approaches to reduce cardiovascular risk
  • Supportive care for emergency department patients

The research reflects a strong interest in faster, more effective care for serious circulatory conditions.

02 Diabetes and Metabolic Disease Studies

Several trials are centered on type 1 diabetes and related nutritional and metabolic diseases, including efforts to lower long-term cardiovascular complications. The research is aimed at testing whether more intensive care strategies and new treatment options can improve health outcomes for people living with diabetes.

  • Intensified care for people with type 1 diabetes at high cardiovascular risk
  • Evaluating protective treatment options for heart-related complications
  • Improving long-term disease control in diabetes

These studies combine prevention and treatment research to support better chronic disease management.

03 Bone, Joint, and Musculoskeletal Research

Research in musculoskeletal diseases includes trials for diabetic acute Charcot foot, a serious complication that can affect mobility and bone health. The main purpose is to evaluate whether a new treatment approach can improve healing and protect patients from further damage.

  • Treatment options for acute Charcot foot in diabetes
  • Restoring function and reducing complications
  • Clinical outcomes in diabetic foot care

This area of research is especially important for preserving movement and quality of life.

04 Ear, Nose, and Throat Research

Trials in otorhinolaryngologic diseases are focusing on chronic rhinosinusitis with nasal polyps, also known as CRSwNP. These studies are assessing whether patients who have responded well to biologic treatment can safely reduce or stop therapy without symptoms returning.

  • Long-term management of nasal polyps
  • Testing the durability of biologic treatment responses
  • Reducing treatment burden while maintaining disease control

This research aims to make care more tailored for people with persistent sinus disease.

05 Digestive System and Gastrointestinal Research

Clinical trials in digestive system diseases are investigating bile acid diarrhoea, with the goal of improving stool consistency and overall symptom control. The studies are evaluating whether a new tablet formulation can provide meaningful relief compared with placebo.

  • Symptom control in bile acid diarrhoea
  • Testing a new treatment for better bowel function
  • Improving quality of life for patients with chronic diarrhoea

These trials focus on practical treatment benefits that matter in everyday care.

06 Hormonal and Chronic Disease Care

Trials linked to hormonal diseases are also part of the research landscape, especially through studies involving diabetes-related complications and broader chronic disease management. The aim is to better understand how targeted therapies can support patients with complex, long-term conditions.

  • Chronic disease control in people with endocrine-related conditions
  • Supporting safer treatment strategies
  • Exploring therapies that may improve long-term outcomes

In Køge, this area connects closely with ongoing diabetes research and prevention-focused care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.